NHS AAA Screening Programme proves its effectiveness

A review of data has found that AAA screening in the UK has been effective and has contributed substantially to ongoing reductions in AAA-related deaths.
Sophie is a screening data analyst in the UK NSC secretariat. She has been working in screening since 2019 and previously had roles as a screening and immunisation coordinator in the South East of England and as National Data Manager for the sickle cell and thalassaemia and infectious diseases in pregnancy screening programmes.
A review of data has found that AAA screening in the UK has been effective and has contributed substantially to ongoing reductions in AAA-related deaths.
The importance of the NHS screening programmes to the public’s health is underlined in a high level summary of data from the NHS Screening Programmes in England for the screening year 2021 to 2022.
The NHS Abdominal Aortic Aneurysm (AAA) screening programme annual standards report for 2023 to 2024 has been published.
The UK National Screening Committee (UK NSC) advises ministers and the NHS in the 4 UK countries about all aspects of population screening and supports implementation of
screening programmes.